A mitochondrial delivery system using liposome-based nanocarriers that target myoblast cells
Takashi Katayama(Hokkaido University), Yuma Yamada(Hokkaido University), Takashi Yokota(Hokkaido University Hospital), Mitsue Hibino(Hokkaido University), Takaaki Furihata(Juntendo University), Hideyoshi Harashima(Hokkaido University), Arata Fukushima(University of Alberta), Shingo Takada(Hokusho University), Toshihisa Anzai(Hokkaido University), Shintaro Kinugawa(Kyushu University)
Cited by 29
Related Papers
Mitochondrial Electron Transport Complex I Is a Potential Source of Oxygen Free Radicals in the Failing Myocardium
|Circulation Research|1999|700
The Polyethyleneglycol Dilemma: Advantage and Disadvantage of PEGylation of Liposomes for Systemic Genes and Nucleic Acids Delivery to Tumors
|Biological and Pharmaceutical Bulletin|2013|479
Prevalence, Clinical Features, and Prognosis of Acute Myocardial Infarction Attributable to Coronary Artery Embolism
|Circulation|2015|401
Construction, binding properties, metabolism, and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49.
|PubMed|1991|340
An improved linker for single-chain Fv with reduced aggregation and enhanced proteolytic stability
|Protein Engineering Design and Selection|1993|308